CCND1 - cyclin D1 Gene
Also Known as BCL1; PRAD1; U21B31; D11S287E
Species: Homo sapiens
About CCND1
This gene has 6 transcripts (splice variants), 278 orthologues, 18 paralogues and is associated with 77 phenotypes. Ubiquitous expression in skin (RPKM 61.4), liver (RPKM 56.0) and 24 other tissues.
Summary
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]
CCND1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_053056.3 | NP_444284.1 | G1/S-specific cyclin-D1 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables cyclin-dependent protein serine/threonine kinase activator activity |
IDA
IDA: Inferred from direct assay
|
19237565 | GOA |
| enables enzyme binding |
IPI
IPI: Inferred from physical interaction
|
19412162 | GOA |
| enables histone deacetylase binding |
IPI
IPI: Inferred from physical interaction
|
18417529 | GOA |
| enables proline-rich region binding |
IDA
IDA: Inferred from direct assay
|
19124461 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
7568034 | GOA |
| enables protein kinase binding |
IPI
IPI: Inferred from physical interaction
|
8114739 | GOA |
| enables transcription corepressor activity |
IDA
IDA: Inferred from direct assay
|
16569215 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| part of cyclin D1-CDK4 complex |
IPI
IPI: Inferred from physical interaction
|
19237565 | GOA |
| part of cyclin D1-CDK6 complex |
IPI
IPI: Inferred from physical interaction
|
15232106 | GOA |
| part of cyclin-dependent protein kinase holoenzyme complex |
IDA
IDA: Inferred from direct assay
|
8114739 | GOA |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
11793365 | GOA |
| part of transcription repressor complex |
IDA
IDA: Inferred from direct assay
|
16569215 | GOA |
CCND1 Protein Structure
Cyclin_N: Cyclin, N-terminal domain (28 - 152)
Cyclin_C: Cyclin, C-terminal domain (156 - 273)
- 0
- 100
- 200
- 295 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
G1/S-specific cyclin-D1 |
|
CCND1 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
CCND1 | P24385 | q96te0_human | Homo sapiens | Q96TE0 | 25416956 | |
|
Intra
|
CCND1 | P24385 | q96te0_human | Homo sapiens | Q96TE0 | 25416956 | |
|
Intra
|
CCND1 | P24385 | NRF1 | Homo sapiens | Q16656 | 16864783 | |
|
Intra
|
CCND1 | P24385 | NRF1 | Homo sapiens | Q16656 | 16864783 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 24218572 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 9106657 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 31515488 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 7568034 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 31217276 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 27107012 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 28514442 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 25502805 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 8756624 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 19237565 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 9106657 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 25416956 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 33961781 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 24855949 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 23543736 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 25416956 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 34591642 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 16431923 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 19237565 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 31217276 | |
|
Intra
|
CCND1 | P24385 | CDK4 | Homo sapiens | P11802 | 27107012 | |
|
Intra
|
CCND1 | P24385 | CDK6 | Homo sapiens | Q00534 | 34591642 | |
|
Intra
|
CCND1 | P24385 | BRCA1 | Homo sapiens | P38398 | 17334399 | |
|
Intra
|
CCND1 | P24385 | BRCA1 | Homo sapiens | P38398 | 17334399 | |
|
Intra
|
CCND1 | P24385 | CDKN1A | Homo sapiens | P38936 | 34591642 | |
|
Intra
|
CCND1 | P24385 | CDKN1A | Homo sapiens | P38936 | 28514442 | |
|
Intra
|
CCND1 | P24385 | CDKN1A | Homo sapiens | P38936 | 25416956 | |
|
Intra
|
CCND1 | P24385 | CDKN1A | Homo sapiens | P38936 | 21988832 | |
|
Intra
|
CCND1 | P24385 | CDKN1A | Homo sapiens | P38936 | 21516116 | |
|
Intra
|
CCND1 | P24385 | CDKN1A | Homo sapiens | P38936 | 31515488 | |
|
Intra
|
CCND1 | P24385 | CDKN1A | Homo sapiens | P38936 | 9106657 | |
|
Intra
|
CCND1 | P24385 | CDK2 | Homo sapiens | P24941 | 34591642 | |
|
Intra
|
CCND1 | P24385 | CDK2 | Homo sapiens | P24941 | 9840943 | |
|
Intra
|
CCND1 | P24385 | CDK2 | Homo sapiens | P24941 | 33961781 | |
|
Intra
|
CCND1 | P24385 | CDK2 | Homo sapiens | P24941 | 28514442 | |
|
Intra
|
CCND1 | P24385 | CDKN1B | Homo sapiens | P46527 | 26496610 | |
|
Intra
|
CCND1 | P24385 | CDKN1B | Homo sapiens | P46527 | 33961781 | |
|
Intra
|
CCND1 | P24385 | CDKN1B | Homo sapiens | P46527 | 28514442 | |
|
Intra
|
CCND1 | P24385 | CDKN1B | Homo sapiens | P46527 | 34591642 | |
|
Intra
|
CCND1 | P24385 | CDKN1B | Homo sapiens | P46527 | 16431923 | |
|
Intra
|
CCND1 | P24385 | HDAC3 | Homo sapiens | O15379 | 16461912 | |
|
Intra
|
CCND1 | P24385 | HDAC3 | Homo sapiens | O15379 | 16461912 | |
|
Intra
|
CCND1 | P24385 | AR | Homo sapiens | P10275 | 16461912 | |
|
Intra
|
CCND1 | P24385 | AR | Homo sapiens | P10275 | 16461912 | |
|
Intra
|
CCND1 | P24385 | FBXO31 | Homo sapiens | Q5XUX0 | 19412162 | |
|
Intra
|
CCND1 | P24385 | FBXO31 | Homo sapiens | Q5XUX0 | 19412162 | |
|
Cross
|
CCND1 | P24385 | N | Human SARS coronavirus | P59595 | 16431923 | |
|
Cross
|
CCND1 | P24385 | Cdk4 | Mus musculus | P30285 | 19409388 | |
|
Intra
|
CCND1 | P24385 | CDC27 | Homo sapiens | P30260 | 20439707 |
Recombinant CCND1 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72119 | CCND1 Protein, Human (His) | P24385 (M1-I295) | ≥ 90%, as determined by reducing SDS-PAGE. |
CCND1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P80098 | Cyclin D1/CCND1 Antibody (YA485) | WB, ICC/IF, IHC-P, IP | Human, Mouse, Rat |
| HY-P80633 | Cyclin D1/CCND1 Antibody | WB, IHC-P, IP | Human, Mouse, Rat |
| HY-P84203 | Cyclin D1/CCND1 Antibody (YA3900) | IHC-P, ICC/IF, FC, ELISA | Human |
| HY-P84203A | Cyclin D1/CCND1 Antibody (YA3900)(PBS only) | IHC-P, ICC/IF, FC, ELISA | Human |
| HY-P84204 | Cyclin D1/CCND1 Antibody (YA3901) | WB, IHC-P, FC, ELISA | Human, Mouse |
| HY-P84204A | Cyclin D1/CCND1 Antibody (YA3901)(PBS only) | WB, IHC-P, FC, ELISA | Human, Mouse |
| HY-P85114 | Cyclin D1/CCND1 Antibody (YA4806) | WB, ELISA | Human |
| HY-P86563 | Cyclin D1/CCND1 Antibody (YA6255) | WB, IHC-P, ICC/IF, IP, ELISA | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Von Hippel-Lindau Syndrome |
|
|
| Myeloma, Multiple |
|
|
| Mantle Cell Lymphoma |
|
|
| Leukemia, Chronic Lymphocytic |
|
|
| Colorectal Cancer |
|
|
| Cervical Cancer |
|
|
| Plasma Cell Leukemia |
|
|
| Lymphoma |
|
|
| Parathyroid Adenoma |
|
|
| Parathyroid Carcinoma |
|
|
| B-Cell Lymphoma |
|
|
| Adenoma |
|
|
| Squamous Cell Carcinoma |
|
|
| Retinoblastoma |
|
|
| Hairy Cell Leukemia |
|
|
| Adenocarcinoma |
|
|
| Larynx Cancer |
|
|
| Familial Adenomatous Polyposis |
|
|
| Barrett Esophagus |
|
|
| Breast Ductal Carcinoma |
|
|
| Breast Cancer |
|
|
| Laryngeal Squamous Cell Carcinoma |
|
|
| Endometrial Cancer |
|
|
| Tonsil Squamous Cell Carcinoma |
|
|
| Follicular Lymphoma |
|
|
| Desmoid Tumor |
|
|
| Leukemia |
|
|
| Lymphoma, Mucosa-Associated Lymphoid Type |
|
|
| Pancreatic Adenocarcinoma |
|
|
| Adenoid Cystic Carcinoma |
|
|
| Inverted Papilloma |
|
|
| Lung Cancer |
|
|
| Bladder Cancer |
|
|
| Amyloidosis |
|
|
| Prolymphocytic Leukemia |
|
|
| Esophageal Cancer |
|
|
| Clear Cell Adenocarcinoma |
|
|
| Anaplastic Astrocytoma |
|
|
| Lymphoma, Non-Hodgkin, Familial |
|
|
| Plasmacytoma |
|
|
| Pancreatic Cancer |
|
|
| Hyperparathyroidism 2 With Jaw Tumors |
|
|
| Waldenstroem'S Macroglobulinemia |
|
|
| Bile Duct Cancer |
|
|
| Endometrial Hyperplasia |
|
|
| Liposarcoma |
|
|
| Ganglioglioma |
|
|
| Glioblastoma |
|
|
| Hepatocellular Carcinoma |
|
|
| Papilloma |
|
|
| Ovarian Cancer |
|
|
| Gastric Cancer |
|
|
| Squamous Cell Carcinoma, Head And Neck |
|
|
| Cervical Squamous Cell Carcinoma |
|
|
| Melanoma |
|
|
| Vulva Cancer |
|
|
| Leiomyosarcoma |
|
|
| Bone Cancer |
|
|
| Prolactinoma |
|
|
| Retinal Cancer |
|
|
| Gastroesophageal Reflux |
|
|
| Ewing Sarcoma |
|
|
| Neuroendocrine Tumor |
|
|
| Tongue Carcinoma |
|
|
| Prostate Cancer |
|
|
| Hepatoblastoma |
|
|
| Esophagus Verrucous Carcinoma |
|
|
| Chordoma |
|
|
| Marginal Zone B-Cell Lymphoma |
|
|
| Skin Carcinoma |
|
|
| Complement Component 9 Deficiency |
|
|
| Gastrointestinal Lymphoma |
|
|
| Pancreatic Foamy Gland Adenocarcinoma |
|
|
| Female Breast Cancer |
|
|
| Esophagus Squamous Cell Carcinoma |
|
|
| Lip And Oral Cavity Cancer |
|
|
| Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
|
|
| Mast-Cell Leukemia |
|
|
| Acquired Immunodeficiency Syndrome |
|
|
| B-Cell Prolymphocytic Leukemia |
|
|
| Extramedullary Plasmacytoma |
|
|
| Skin Papilloma |
|
|
| Paraganglioma |
|
|
| Colon Adenoma |
|
|
| Ocular Cancer |
|
|
| Rhabdomyosarcoma |
|
|
| Thyroid Gland Cancer |
|
|
| Laryngeal Benign Neoplasm |
|
|
| Breast Carcinoma In Situ |
|
|
| Colon Adenocarcinoma |
|
|
| Estrogen-Receptor Positive Breast Cancer |
|
|
| Lymphoplasmacytic Lymphoma |
|
|
| Colon Lymphoma |
|
|
| Pre-Malignant Neoplasm |
|
|
| Gallbladder Cancer |
|
|
| Ureteral Lymphoma |
|
|
| Spleen Cancer |
|
|
| Medulloblastoma |
|
|
| Ductal Carcinoma In Situ |
|
|
| Lung Cancer Susceptibility 3 |
|
|
| Nasopharyngeal Carcinoma |
|
|
| Nodular Malignant Melanoma |
|
|
| Splenic Marginal Zone Lymphoma |
|
|
| Monoclonal Gammopathy Of Uncertain Significance |
|
|
| Estrogen-Receptor Negative Breast Cancer |
|
|
| In Situ Carcinoma |
|
|
| Colonic Benign Neoplasm |
|
|
| Pheochromocytoma |
|
|
| Intestinal Benign Neoplasm |
|
|
| Microphthalmia |
|
|
| Amelogenesis Imperfecta, Type Ig |
|
|
| Mature B-Cell Neoplasm |
|
|
| Respiratory System Benign Neoplasm |
|
|
| Neuroblastoma |
|
|
| Infected Hydrocele |
|
|
| Breast Lobular Carcinoma |
|
|
| Lung Adenoma |
|
|
| Vulvar Disease |
|
|
| Uterine Benign Neoplasm |
|
|
| Gastrointestinal System Benign Neoplasm |
|
|
| Retinal Disease |
|
|
| Oropharynx Cancer |
|
|
| Reproductive Organ Benign Neoplasm |
|
|
| Esophagus Adenocarcinoma |
|
|
| Basal Cell Nevus Syndrome |
|
|
| Hypopharynx Cancer |
|
|
| Colorectal Adenoma |
|
|
| Lymphangioma |
|
|
| Bladder Papillary Transitional Cell Neoplasm |
|
|
| Urinary Tract Papillary Transitional Cell Benign Neoplasm |
|
|
| Appendix Lymphoma |
|
|
| Infratentorial Cancer |
|
|
| Human Papillomavirus Infectious Disease |
|
|
| Breast Adenocarcinoma |
|
|
| Skin Squamous Cell Carcinoma |
|
|
| Tonsil Cancer |
|
|
| Endometrial Stromal Sarcoma |
|
|
| Synchronous Bilateral Breast Carcinoma |
|
|
| Inflammatory Bowel Disease |
|
|
| Sensory System Disease |
|
|
| Colorectal Adenocarcinoma |
|
|
| Melanoma, Cutaneous Malignant 1 |
|
|
| Kidney Clear Cell Sarcoma |
|
|
| Leukocyte Disease |
|
|
| Bone Marrow Cancer |
|
|
| Peripheral Nervous System Neoplasm |
|
|
| Autonomic Nervous System Neoplasm |
|
|
| Cell Type Benign Neoplasm |
|
|
| Tongue Disease |
|
|
| Thyroid Gland Follicular Carcinoma |
|
|
| Cholangiocarcinoma |
|
|
| Bone Squamous Cell Carcinoma |
|
|
| Renal Cell Carcinoma, Nonpapillary |
|
|
| Head And Neck Cancer |
|
|
| Atypical Teratoid Rhabdoid Tumor |
|
|
| Amelogenesis Imperfecta |
|
|
| Gallbladder Disease |
|
|
| Plasma Cell Neoplasm |
|
|
| Cervix Carcinoma |
|
|
| Eye Disease |
|
|
| Thyroid Gland Anaplastic Carcinoma |
|
|
| Chromophobe Renal Cell Carcinoma |
|
|
| Gastrointestinal Stromal Tumor |
|
|
| Melanoma, Uveal |
|
|
| Lynch Syndrome |
|
|
| Wilms Tumor 1 |
|
|
| Peripheral Nervous System Disease |
|
|
| Leukemia, Acute Myeloid |
|
|
| Meningioma, Familial |
|
|
| Nervous System Disease |
|
|
| Skin Disease |
|
|
| Acute Promyelocytic Leukemia |
|
|
| Connective Tissue Disease |
|
|
| Retinitis Pigmentosa |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Macaca mulatta | CCND1 | VGNC | VGNC:70723 |
| Canis familiaris | CCND1 | VGNC | VGNC:54266 |
| Bos taurus | CCND1 | VGNC | VGNC:26962 |
| Felis catus | CCND1 | VGNC | VGNC:60555 |
| Mus musculus | CCND1 | MGD | MGI:88313 |
| Rattus norvegicus | CCND1 | RGD | RGD:68384 |
| Others | CCND1 | NCBI |